Academics & Research
Sri Shankara Cancer Hospital and Research Centre firmly believe that academic activities and high-quality oncological care go hand in hand. Our weekly tumour board meetings witness several intense discussions between all specialists and resident doctors to come up with the best treatment plan for the patients, these meetings double up as a great learning opportunity for our students. In addition to this, Saturdays are dedicated to academic activities such as journal club sessions, continuous professional education activities and guest lectures/panel discussions by eminent scientists, doctors and professionals from the industry.
We conduct several National Board of Examinations (NBE) and Rajiv Gandhi University of Health Sciences (RGUHS) recognized academic courses to nurture and train the future leaders in oncological care and research.
Under the guidance of eminent scientists of our Academic Advisory Board and Institutional Ethics Committee, our research wing is rapidly growing with collaborations with other research inclined national and international centres.
Sri Shankara Cancer Foundation is also recognized by the Department of Scientific & Industrial Research, Government of India.
Super Speciality Courses
Diplomate of National Board of Examinations (DNB)
Sri Shankara Cancer Hospital and Research Centre has been recognised and accredited by the National Board of Examinations (NBE) to conduct Diplomate of the National Board (DNB) Post Graduate Degree Programmes in:
DNB - Radiotherapy
DNB - Surgical Oncology
DNB - Medical Oncology
DNB - Gynaec-Oncology
Rajiv Gandhi University of Health Sciences has recognised Sri Shankara Cancer Hospital and Research Centre as a fellowship centre for
Interventional Radiology (Autonomous Fellowship of SSCHRC)
Sri Shankara Cancer Hospital and Research Centre has an MoU with Maastricht University, Netherlands that enables our clinicians, scientists and staff to enroll in a PhD programme at the university while continuing their work at the hospital.
To more about the PhD and other academic programmes, Contact:
Dr. Kishore Murthy, Director of Academics and Quality
Dr. Kishore Murthy
Director of Academics and Quality
Phone: 080 - 26981033
Continuous Professional Education
Sri Shankara Cancer Hospital and Research Centre regularly conducts continuous professional education programmes such as CME, CDE, CNE and Symposia to train and update both in house and external professionals in the field of oncology.
09.03.2014 - SSCHRC/CPE - 001
11.05.2014 - SSCHRC/CPE - 002
Symposium on Modern Radiotherapy – Current Practices and Future Directions
09.08.2014 - SSCHRC/CPE - 003
An insight into Thyroid Malignancy
18.10.2014 - SSCHRC/CPE - 004
Pink month – Breast Cancer Awareness
29.11.2014 - SSCHRC/CPE - 005
Approach to Modern Management of Lung Cancer
07.02.2015 - SSCHRC/CPE - 006
Cervical Cancer – New Perspectives
22.08.2015 - SSCHRC/CPE - 007
Perioperative Management of Abdominal Surgical Patients
12.09.2015 - SSCHRC/CPE - 008
Current Concepts in Management of Shoulder Pain
06.12.2015 - SSCHRC/CPE - 009
The first Shankara Conclave on Uro Oncology and MR based planning
20.02.2016 - SSCHRC/CPE - 010
Recent Advances in Neuro Oncology
09.04.2016 - SSCHRC/CPE - 011
18.04.2016 - SSCHRC/CPE - 012
Overview of Urological Malignancies
20.04.2016 - SSCHRC/CPE - 013
General Practitioners CME programme
21.05.2016 - SSCHRC/CPE - 014
SSCHRC Cancer Palliative Care Group Meet -1
30.07.2016 - SSCHRC/CPE - 015
CME on IV fluids
10.09.2016 - SSCHRC/CPE - 016
SSCHRC Cancer Palliative Care Group Meet - 2
30.09.2016 - SSCHRC/CPE - 017
01.10.2016 - SSCHRC/CPE - 018
Challenges and Current Trends in Management of Head, Neck and Upper GI Malignancies
19.08.2017 - SSCHRC/CPE - 019
Bridging the Gap in Oral Oncology
02.09.2017 - SSCHRC/CPE - 020
09.09.2017 and 10.09.2017 - SSCHRC/CPE - 021
Refresher course in Brachytherapy
16.09.2017 - SSCHRC/CPE - 022
Dilemmas and Controversies in Thyroid Cancer and Surgery
25.09.2018 - SSCHRC/CPE - 023
19.01.2019 - SSCHRC/CPE - 024
Bangalore Palliative Care Initiative Group and SSCHRC Cancer Palliative Care Group Meet
18.08.2019 - SSCHRC/CPE - 025
Updates in Pediatric Oncology and Hematology – Oncology in Pediatric office Practice
24.08.2019 - SSCHRC/CPE - 026
Symposium on Maxillofacial Prosthesis
08.02.2020 - SSCHRC/CPE - 027
Navigating the Challenges in the PATH of Gyn Oncology - CME in Gynaec Onco Pathology
06.02.2020 - SSCHRC/CPE - 028
A 2020 Vision of Onco Anaesthesia
For more details on Academic Programmes and Activities, Contact:
Academics and Research, Sri Shankara Cancer Hospital and Research Centre
SSCHRC has a separate Research Wing with several research publications in National and International peer reviewed journals. Our Academic/Research Advisory Board and Institutional Ethics Committee members meet once in few months to discuss and mentor our research scientists and physicians in the following areas
Preventive and Community Oncology Research
Research in Nuclear Medicine
Research in Radiotherapy
Research in Holistic Sciences and Cancer Care
Establishment of Biobank
Research in Molecular Biology
APPROVED BY IEC on JANUARY 13th, 2017
SSCF/Res - 009
A randomized control study to evaluate the effectiveness of turmeric mouthwash on Oral Health Status, treatment induced Oral Mucositis and associated Oral Dysfunctions among patients with head and neck cancer.
SSCF/Res - 010
A Study on Cardiac Sparing Radiotherapy In Left Breast Carcinoma Patients - Dosimetric Comparison of Various Techniques
SSCF/Res - 011
Pilot Study of Radiation Dose Escalation In The Treatment of Carcinoma Esophagus undergoing Concurrent Chemoradiation
SSCF/Res - 012
Clinical profile of patients with triple negative breast carcinoma Trainee.
SSCF/Res - 013
Comparative Study of Dose to Small Bowel, Bone Marrow and Femur Between 3 Different Radiotherapy Techniques –3D Conformal Radiotherapy (3DCRT), Intensity Modulated Radiotherapy (IMRT) And Rotational Intensity Modulated Radiotherapy in The Treatment of Carcinoma Rectum
APPROVED BY IEC ON January 11th, 2019
SSCF/Res - 032
A study on the prescribing pattern and outcone measure for prophylactic Anti-Emetic medications in chemotherapy induced Nausea and Vomiting
SSCF/Res - 033
A study to assess the Management of hypertension for pre and post-operative care hypertensive cancer patients
SSCF/Res - 034
Utilization study of antibiotics in febrile neutropenic cancer patients with bacteraemia
SSCF/Res - 035
A prospective study on acute adverse effect profile of intravenous zoledronic acid in cancer patients
SSCF/Res - 036
A Study On Quality of Life and Assessment of Adverse Drug Reaction of Tyrosine Kinase Inhibitors in Management of Solid organ malignancies
APPROVED BY IEC ON AUGUST 26TH, 2016
SSCF/Res - 001
Critical assessment and standardization of sentinel lymph node mapping in early endometrial cancer
SSCF/Res - 002
Study of Utility of MR Diffusion Tensor Imaging (Tractography) In Radiotherapy Planning for High Grade Gliomas
SSCF/Res - 003
Development of an in vivo immunocompromised mice model system using breast tumor specimens from patient samples
SSCF/Res - 004
Retrospective study to evaluate molecular markers of prognosis, treatment response and disease outcomes in breast cancer
APPROVED BY IEC ON JANUARY 13th, 2017
SSCF/Res - 005
Gamma probe-guided sentinel node Radiolocalization in cancer of anterior one third tongue and Buccal Mucosa / Gingivobuccal sulcus”
SSCF/Res - 006
Radiotherapy Dose escalation by Simultaneous Integrated Boost Radiotherapy (SIB), combined with chemotherapy for esophageal cancers – Toxicity & Early outcomes”
SSCF/Res - 007
Multidrug resistance protein imaging in lung - a mechanistic study”
SSCF/Res - 008
Fluoride application - prevention for dental caries in radiation therapy patient for Head and neck cancer
APPROVED BY IEC ON MAY 26th, 2017
SSCF/Res - 014
Prevention of Cancer: A longitudinal Interventional study in Gauribidanur Taluk
SSCF/Res - 015
Evaluation of Mesenchymal stem cells from oral precancerous lesions and OSCCs [Oral squamous cell carcinoma] towards development of novel biomarkers for efficient prediction of prognosis for oral cancer.
APPROVED BY IEC ON OCTOBER 27th, 2017
SSCF/Res - 016
Understanding the molecular mechanisms of acquired drug resistance in epithelial ovarian cancer
SSCF/Res - 017
Genetic and Epigenetic landscape of acquired chemoresistance in cancer
SSCF/Res - 018
Investigating N-glycomic dynamics in ovarian cancer metastasis
SSCF/Res - 019
Role of breast MRI in breast cancer patients receiving Neoadjuvant chemotherapy (NACT)
SSCF/Res - 020
Establishment of primary Breast Tumor 3D culture Models to assess response to Therapeutics in vitro
APPROVED BY IEC ON MARCH 23rd, 2018
SSCF/Res - 021
Customized 3D printed Titanium Implants for reconstruction of Maxilla and Mandible following Oral Cancer Surgery
APPROVED BY IEC ON AUGUST 3rd, 2018
SSCF/Res - 022
Development of a Novel Approach for detection and analysis of digital mammogram
SSCF/Res - 023
A comparative study of palpation guided lumpectomy, ultrasound guided lumpectomy and cavity shaving technique for attaining negative margins in breast conservation surgery
SSCF/Res - 024
Comparison of RENAL, PADUA, ABC and C-index scoring systems in predicting perioperative outcomes after nephron sparing surgery
APPROVED BY IEC ON JANUARY 11th, 2019
SSCF/Res - 025
Genomic studies of Oral Submucous Fibrosis
SSCF/Res - 026
Establishment of Indian GI cancer Biobank and examination of molecular landscape of Indian GI cancer
SSCF/Res - 027
Evaluation of BRCA 1 dysfunction and DNB damage repair (DDR) deficiency by estimation of BRCA 1 and other DNA damage repair proteins by multimodality testing in Epithelial ovarian cancer (EOC)
SSCF/Res - 028
Role of GA 68 PSMA CT in evaluating recurrence in previously treated patients with glioma of the brain
SSCF/Res - 029
Targetted Alpha Therapy – New beginnings
SSCF/Res - 030
Efficacy of topical alpha adrenergic vasoconstrictor in prevention of chemotherapy induced alopecia: A pilot study.
SSCF/Res - 031
A prospective Study to compare the efficacy of topical Morphine mouth wash with standard Benzydamine oral mouth wash in the management of Oral mucositis in patients undergoing head and neck radiotherapy or Concurrent chemoradiotherapy
APPROVED BY IEC ON JULY 20TH, 2019
SSCF/Res - 037
Development and evaluation of an intervention to enhance resilience in breast cancer
SSCF/Res - 038
Breast Cancer in Premenopausal women – Evaluation of the role of circulating steroid hormones in resistance to therapy St. Johns Research Institute, Bangalore.
SSCF/Res - 039
Randomized trial of preoperative chemotherapy followed by surgery and adjuvant chemoradiation versus preoperative chemoradiation followed by surgery and adjuvant chemoradiotherapy for locally advanced operable Adenocarcinoma of gastroesophageal junction or gastric carcinoma
SSCF/Res - 040
A study to assess the knowledge and experiences of workplace incivility and its impact among staff nurses in selected hospitals Bengaluru
APPROVED BY IEC ON DECEMBER 21ST 2019
SSCF/Res - 041
Critical Analysis of Adding Neoadjuvant Chemotherapy to Standard Regimen In Carcinoma Cervix Stage III C and IVA
SSCF/Res - 042
A Pilot Study of the Role of Local Consolidative Radiotherapy Following Systemic Chemotherapy on Well Controlled Limited Metastatic Non Small Cell Lung Cancer
SSCF/Res - 043
A pilot study comparing chemo- radiotherapy versus neoadjuvant chemoradiation followed by surgery in locally advanced carcinoma cervix
SSCF/Res - 044
Microsatellite instability (MSI) in metastatic gastrointestinal cancers
SSCF/Res - 045
Assessment of miRNA signature and its correlation with clinic-pathological profile of Indian colorectal cancer patients in a tertiary care hospital
SSCF/Res - 046
Molecular assessment of margins of oral squamous cell carcinoma and to determine its prognostic significance
SSCF/Res - 047
Study of stem cell biomarker in tumour and adjacent tissue in breast cancer to predict the prognosis
SSCF/Res - 048
Comparison of Salivary Amylase levels, Salivary Scintigraphy and Diffusion Weighted Magnetic Resonance Imaging in evaluation of Xerostomia in Carcinoma of Nasopharynx, Oropharynx, Hypopharynx and Larynx patients treated with Intensity Modulated Radiotherapy
SSCF/Res - 049
Prospective study of MRI based interfractional changes in position of intracavitary brachytherapy applicator with respect to urinary bladder, bowel and rectum during brachytherapy in patients with carcinoma cervix
SSCF/PBN - 001
Follicle-Stimulating Hormone Is an Autocrine Regulator of the Ovarian Cancer Metastatic Niche Through Notch Signaling.
Gera S, Kumar S S, Swamy SN, Bhagat R, Vadaparty A, Gawari R, Bhat R, Dighe RR.
J Endocr Soc. 2018 Dec 12;3(2):340-357. doi: 10.1210/js.2018-00272.
SSCF/PBN - 002
Outcomes of Computed Tomography-Guided Image-Based Interstitial Brachytherapy for Cancer of the Cervix Using GEC-ESTRO Guidelines.
Rishi KS, Alva RC, Kadam AR, Sharma S.
Indian J Surg Oncol. 2018 Jun;9(2):181-186. doi: 10.1007/s13193-018-0738-6.
SSCF/PBN - 003
The Impact of Breast Cancer on the Patient and the Family in Indian Perspective.
Alexander A, Kaluve R, Prabhu JS, Korlimarla A, Srinath BS, Manjunath S, Patil S, Gopinath KS, Sridhar TS.
Indian J Palliat Care. 2019 Jan-Mar;25(1):66-72. doi: 10.4103/IJPC.IJPC_158_18.
SSCF/PBN - 004
HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K, Aiyappa R, Prabhu JS, Nair MG, Lawrence PV, Korlimarla A, Ce A, Alexander A, Kaluve RS, Manjunath S, Correa M, Srinath BS, Patil S, Kalamdani A, Prasad M, Sridhar TS.
Tumour Biol. 2017 Mar;39(3):1010428317695028. doi: 10.1177/1010428317695028.
SSCF/PBN - 005
Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study.
Ramaswamy A, Ostwal V, Pande N, Sharma A, Patil S, Thippeswamy R, Ghadyalpatil N, Roy R, Peshwe H, Poladia B, Rajamanickam D, Rangarajan B, Neelesh Reddy PR, Pandita V, Mukherjee A, Thoke A, Sarkar A, Satish CT, Shashidara H, Banavali SD.
South Asian J Cancer. 2019 Jan-Mar;8(1):22-26. doi: 10.4103/sajc.sajc_173_18.
SSCF/PBN - 006
Vascular endothelial growth factor polymorphisms and a synchronized examination of plasma and tissue expression in epithelial ovarian cancers.
Bhaskari J, Premalata CS, Shilpa V, Rahul B, Pallavi VR, Ramesh G, Krishnamoorthy L.
Tumour Biol. 2016 Jan;37(1):1017-23. doi: 10.1007/s13277-015-3891-3.
SSCF/PBN - 007
Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast Cancer.
Korlimarla A, Prabhu JS, Remacle J, Rajarajan S, Raja U, C E A, Srinath BS, Manjunath S, K S G, Correa M, M S N P, Sridhar TS.
PLoS One. 2016 Apr 4;11(4):e0153113. doi: 10.1371/journal.pone.0153113
SSCF/PBN - 008
Study of dosimetric properties of flattened and unflattened megavoltage x ray beam on high Z implant materials.
Rajamanickam T, Muthu S, Murugan P, Pathokonda M, Senthilnathan K, Arunai Nambi Raj N, Ramesh Babu P.
J Appl Clin Med Phys. 2018 Nov;19(6):265-273. doi: 10.1002/acm2.12451
SSCF/PBN - 009
The role of hybrid bone SPECT/CT imaging in the work-up of the limping patient: a symptom-based and joint-oriented review.
Mohan HK, Strobel K, van der Bruggen W, Gnanasegaran G, Kampen WU, Kuwert T, Van den Wyngaert T, Paycha F.
Eur J Hybrid Imaging. 2018;2(1):8. doi: 10.1186/s41824-018-0026-2.
SSCF/PBN - 010
Implementation and Evaluation of Phantomless Intensity Modulated Radiotherapy Delivery Verification Using FractionCHECK.
Reddy BR, Ravikumar M, Varatharaj C, Childress N, Vivek TR.
Gulf J Oncolog. 2019 Sep;1(31):26-35
SSCF/PBN - 011
Studies on Fundamental Interaction Parameters for Stainless Steel and Titanium Biomaterials Using Flattened and Un-Flattened Megavoltage X-Ray Beams.
Rajamanickam T, Muthu S, Murugan P, Pathikonda M, Senthilnathan K, Nambi Raj NA, Ramesh Babu P.
Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2485-2491 doi:10.31557/APJCP.2019.20.8.2485
SSCF/PBN - 012
An Assessment of Dosimetric Characteristics of Inline 2.5 Mega Voltage Unflattened Imaging X-Ray Beam.
Rajamanickam T, Muthu S, Murugan P, Dinesan C, Mekala C, Senthilnathan K, Arunai Nambi Raj N, Ramesh Babu P.
Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2531-2539. doi:10.31557/APJCP.2019.20.8.2531.
SSCF/PBN - 013
Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease.
Prabhu JS, Korlimarla A, Anupama CE, Alexander A, Raghavan R, Kaul R, Desai K, Rajarajan S, Manjunath S, Correa M, Raman R, Kalamdani A, Prasad M, Patil S, Gopinath KS, Srinath BS, Sridhar TS.
Transl Oncol. 2017 Aug;10(4):699-706. doi: 10.1016/j.tranon.2017.04.011.
SSCF/PBN - 014
High expression of integrin β6 in association with the Rho–Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers K Desai, M G Nair, J S Prabhu, A Vinod, A Korlimarla, S Rajarajan, Aiyappa, R S Kaluve, A Alexander, P S Hari, G Mukherjee, R V Kumar, S Manjunath, M Correa, B S Srinath, S Patil, M. S. N. Prasad, K. S. Gopinath, R N. Rao5, S M. Violette, P H. Weinreb & T. S. Sridhar
Cancer Medicine 2016; 5(8):2000–2011 doi: 10.1002/cam4.756
SSCF/PBN - 015
A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors.
Prabhu JS, Korlimarla A, Desai K, Alexander A, Raghavan R, Anupama C, Dendukuri N, Manjunath S, Correa M, Raman N, Kalamdani A, Prasad M, Gopinath KS, Srinath BS, Sridhar TS.
J Cancer. 2014 Jan 23;5(2):156-65. doi: 10.7150/jca.7668
SSCF/PBN - 016
Gemcitabine and nab-paclitaxel based regimen in advanced pancreatic carcinoma at tertiary cancer centre, Bangalore
Satheesh Thungappa, P Shashidhara, Ravi Thippeswamy, Shekar Patil
Annals of Oncology, Volume 28, Issue suppl_3, June 2017,
SSCF/PBN - 017
Outcomes in lung cancer: An experience from routine tertiary care setting.
Thippeswamy R, Patil S, Prashanth P, Sateesh C T, Vittal T, Shashidhara H P, Haridas K M
Indian J Cancer 2017;54:276-9; DOI: 10.4103/0019-509X.21960
SSCF/PBN - 018
Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study
Anant R, Vikas O, Nikhil P, Atul S, Shekar P, Ravi T, Nikhil G, Rakesh R, Harish P, Bhavesh P, Deepan R, Bharat R, PR Neelesh R, Vimal P, Ashis M, Aniket T, Abhijit S, CT Satish, H Shashidara, SD Banavali
South Asian J Cancer 2019; 8:1; 22-26; DOI: 10.4103/sajc.sajc_173_18
SSCF/PBN - 019
Slow Growing Nasal Mass - A Rare Finding of Pleomorphic Adenoma in the Nasal Cavity and Review of Surgical Methods
Sanchitha C, Sreeram MP, Prabhat Y, Srinath BS
Acta Scientific Otolaryngology 2.6 (2020): 10-13.
SSCF/PBN - 020
Ectopic cervical thymoma: A diagnostic dilemma.
Kurpad V, Sreeram MP, Sasthry M.
Ann Indian Acad Otorhinolaryngol Head Neck Surg 2020;4:13-5.